Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN\LINAGLIPTIN Cause Cataract? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Cataract have been filed in association with EMPAGLIFLOZIN\LINAGLIPTIN. This represents 0.3% of all adverse event reports for EMPAGLIFLOZIN\LINAGLIPTIN.

5
Reports of Cataract with EMPAGLIFLOZIN\LINAGLIPTIN
0.3%
of all EMPAGLIFLOZIN\LINAGLIPTIN reports
0
Deaths
0
Hospitalizations

How Dangerous Is Cataract From EMPAGLIFLOZIN\LINAGLIPTIN?

Of the 5 reports.

Is Cataract Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN\LINAGLIPTIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN\LINAGLIPTIN Cause?

Diabetic ketoacidosis (149) Blood glucose increased (121) Fungal infection (92) Weight decreased (77) Nausea (68) Dizziness (58) Vomiting (55) Urinary tract infection (52) Euglycaemic diabetic ketoacidosis (49) Dehydration (44)

What Other Drugs Cause Cataract?

ADALIMUMAB (3,157) METHOTREXATE (1,785) INSULIN LISPRO (1,676) LENALIDOMIDE (1,658) ETANERCEPT (1,451) PREDNISONE (1,365) RITUXIMAB (1,332) INSULIN GLARGINE (1,313) ABATACEPT (1,065) TOFACITINIB (1,050)

Which EMPAGLIFLOZIN\LINAGLIPTIN Alternatives Have Lower Cataract Risk?

EMPAGLIFLOZIN\LINAGLIPTIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN\LINAGLIPTIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE EMPAGLIFLOZIN\LINAGLIPTIN vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL

Related Pages

EMPAGLIFLOZIN\LINAGLIPTIN Full Profile All Cataract Reports All Drugs Causing Cataract EMPAGLIFLOZIN\LINAGLIPTIN Demographics